UFP Technologies, Inc.
NASDAQ:UFPTMedical - Devices
+$10.10 today
- Market cap
- $2.37B
- Beta
- 1.10
- P/E (TTM)
- 26.8
- EPS (TTM)
- $8.89
Volume 0.08M
Average 0.21M
UFPT Common Stock Issued
Cash raised by issuing new shares.
UFP Technologies, Inc.NASDAQ: UFPT
Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026
Common stock issued outflow grows to $116K
Q2 FY2026 common stock issued was $116K, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $208K.
Context
- Common stock issued amounted to 0.0% of revenue in FY2025, down 0.9 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly common stock issued holds near $116K or moves back toward the trailing-twelve-month quarterly average of $52K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 194K USD
- Year-over-year change
- +104.1%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 194K | +104.1% |
| FY2024 | 2024-12-31 | (4.72M) | -794.3% |
| FY2023 | 2023-12-31 | 680K | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Common Stock Issued vs competitors
How UFPT compares with its peers on the latest reported figures
- UFPT's LTM Jun 2026 common stock issued of $208K is the 8th largest of the 11 companies compared; the peer median is $2.46M.
- Its year-over-year change of +104.4% is the highest of 8, against a peer median of -14.2%.
- Common stock issued amounts to 0.0% of revenue for UFPT, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $441M | -14.2% | +18.8% | 1.2% | |
| LTM Sep 2026 | $24.81M | -50.5% | +25.1% | 9.4% | |
| LTM Jun 2026 | $12M | — | — | 0.1% | |
| LTM Mar 2026 | $3.4M | -97.1% | -20.4% | 2.7% | |
| LTM Mar 2026 | $3.31M | +21.5% | +15.4% | 1.6% | |
| LTM Apr 2026 | $1.61M | +19.4% | -39.0% | 0.1% | |
| LTM Mar 2026 | $760K | -20.6% | — | 0.0% | |
| LTM Jun 2026 | $208K | +104.4% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding UFPT) | $2.46M | -14.2% | +15.4% | 0.1% | |
Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 15.89M | 41.79M | 44.92M | 58.98M | 68.31M |
| Depreciation & Amortization | 8.41M | 11.89M | 11.41M | 14.72M | 19.15M |
| Deferred Income Tax | (1.79M) | (4.71M) | 816K | 1.33M | 5.11M |
| Stock-Based Compensation | 2.43M | 3.21M | 4.64M | 6.84M | 8.85M |
| Change in Working Capital | (10.62M) | (22.47M) | (24.13M) | (16.34M) | (9.7M) |
| Accounts Receivables | (6.86M) | (15.91M) | (12.11M) | (2.19M) | 4.79M |
| Inventory | (4.5M) | (19.61M) | (16.57M) | (4.69M) | 3.9M |
| Accounts Payables | 102K | 9.13M | 1.55M | (1.14M) | (1.09M) |
| Other Working Capital | 632K | 3.92M | 2.99M | (8.32M) | (17.3M) |
| Other Non-Cash Items | (14K) | (11.96M) | 3.67M | 1.06M | 180K |
| Operating Cash Flow | 14.29M | 17.74M | 41.33M | 66.59M | 91.91M |
| Capital Expenditures | (5.4M) | (13.78M) | (10.49M) | (9.66M) | (12.93M) |
| Acquisitions (Net) | (96.18M) | (20.65M) | 0 | (197.48M) | (14.72M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 114K | 35.72M | 2K | (3.03M) | 51K |
| Investing Cash Flow | (101.46M) | 1.29M | (10.49M) | (210.16M) | (27.6M) |
| Debt Repayment | 74.81M | (20M) | (23M) | 157.3M | (53.92M) |
| Common Stock Issued | 0 | 0 | 680K | (4.72M) | 194K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (761K) | (5.83M) | (7.7M) | (188K) | (4.43M) |
| Financing Cash Flow | 74.05M | (25.89M) | (30.02M) | 152.39M | (58.16M) |
| Effect of Forex Changes | 0 | 193K | (10K) | (635K) | 699K |
| Net Change in Cash | (13.12M) | (6.67M) | 812K | 8.19M | 6.85M |
| Free Cash Flow | 8.9M | 3.96M | 30.84M | 56.94M | 78.98M |
UFP Technologies, Inc.
NASDAQ:UFPT
Intrinsic Alpha fair value
Locked
Current Price
$305.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.